Key Data Points

Primary metrics and data points about Epizyme.
Current Price: $9.35
Prev Close: $9.59
Open: $9.47
Bid: $8.56
Ask: $9.35
Day's Range: $9.19 - $9.77
52wk Range: $8.27 - $28.48
Volume: 557,181
Avg Vol 899,852
Market Cap: $389.93M
P/E (ttm): -2.95
EPS (ttm): -$3.25
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Epizyme.

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

  • Exchange: NASDAQ

Stock Charting

EPZM vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Epizyme.
CAPS Rating 5 out of 5
45 Outperform
5 Underperform
CAPS All Stars
17 Outperform
2 Underperform

Powered by Motley Fool CAPS

More Details about Epizyme

Primary metrics and data points about Epizyme.